🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 14 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/01/1979 | 1,80 | 1,82 | 1,80 | 1,81 | +0,37% | 1,11% | 2.701.325 |
| 02/01/1979 | 1,79 | 1,80 | 1,76 | 1,80 | +0,37% | 2,22% | 2.327.818 |
| 29/12/1978 | 1,80 | 1,81 | 1,79 | 1,79 | -0,18% | 1,11% | 1.312.934 |
| 28/12/1978 | 1,80 | 1,81 | 1,79 | 1,80 | -0,37% | 1,29% | 3.248.381 |
| 27/12/1978 | 1,81 | 1,81 | 1,78 | 1,80 | -1,63% | 2,01% | 3.459.658 |
| 26/12/1978 | 1,81 | 1,84 | 1,80 | 1,83 | +1,28% | 2,20% | 1.822.262 |
| 22/12/1978 | 1,78 | 1,81 | 1,78 | 1,81 | +1,67% | 1,86% | 2.407.046 |
| 21/12/1978 | 1,78 | 1,82 | 1,77 | 1,78 | +0,19% | 2,42% | 4.451.904 |
| 20/12/1978 | 1,69 | 1,78 | 1,69 | 1,78 | +5,51% | 5,31% | 3.780.346 |
| 19/12/1978 | 1,66 | 1,70 | 1,65 | 1,68 | +1,60% | 2,80% | 2.188.224 |
| 18/12/1978 | 1,66 | 1,66 | 1,63 | 1,66 | -1,96% | 2,19% | 2.927.693 |
| 15/12/1978 | 1,71 | 1,71 | 1,69 | 1,69 | -1,16% | 1,16% | 1.863.763 |
| 14/12/1978 | 1,69 | 1,71 | 1,69 | 1,71 | +1,18% | 1,18% | 1.920.355 |
| 13/12/1978 | 1,73 | 1,73 | 1,68 | 1,69 | -2,30% | 2,68% | 4.029.350 |
| 12/12/1978 | 1,74 | 1,76 | 1,73 | 1,73 | -0,76% | 1,71% | 2.437.229 |
| 11/12/1978 | 1,75 | 1,76 | 1,73 | 1,74 | -0,38% | 1,70% | 1.875.082 |
| 08/12/1978 | 1,71 | 1,76 | 1,71 | 1,75 | +2,13% | 3,09% | 3.953.894 |
| 07/12/1978 | 1,70 | 1,73 | 1,69 | 1,71 | +0,78% | 2,54% | 4.625.453 |
| 06/12/1978 | 1,74 | 1,74 | 1,70 | 1,70 | -2,10% | 2,10% | 2.671.142 |
| 05/12/1978 | 1,65 | 1,74 | 1,65 | 1,74 | +5,22% | 5,22% | 3.912.394 |
| 04/12/1978 | 1,63 | 1,67 | 1,62 | 1,65 | +1,22% | 2,84% | 6.406.214 |
| 01/12/1978 | 1,60 | 1,63 | 1,60 | 1,63 | +2,93% | 2,07% | 3.780.346 |
| 30/11/1978 | 1,55 | 1,58 | 1,55 | 1,58 | +2,80% | 2,35% | 2.237.270 |
| 29/11/1978 | 1,57 | 1,57 | 1,54 | 1,54 | -2,31% | 1,90% | 1.697.760 |
| 28/11/1978 | 1,56 | 1,60 | 1,56 | 1,58 | +0,85% | 2,12% | 4.274.582 |
| 27/11/1978 | 1,56 | 1,58 | 1,55 | 1,56 | +0,00% | 1,48% | 845.107 |
| 24/11/1978 | 1,55 | 1,56 | 1,55 | 1,56 | +0,64% | 0,85% | 445.190 |
| 22/11/1978 | 1,57 | 1,58 | 1,55 | 1,55 | -1,06% | 1,48% | 1.546.848 |
| 21/11/1978 | 1,58 | 1,58 | 1,56 | 1,57 | -0,83% | 1,05% | 1.029.974 |
| 20/11/1978 | 1,57 | 1,59 | 1,57 | 1,58 | +0,63% | 1,05% | 2.037.312 |